DR. REDDY’S LAB DR. REDDY’S LAB BY BY TEJASVI YADAV TEJASVI YADAV
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
DR. REDDY’S DR. REDDY’S LAB LAB
BY BY
TEJASVI YADAVTEJASVI YADAV
Overview Overview of Pharmaceutical of Pharmaceutical Industry in IndiaIndustry in India
The Pharmaceutical Industry in India is one of the largest in the world.
It ranks 4th in the world, pertaining to the volume of sales.
The estimated worth of the Indian Pharmaceutical Industry is US$ 6billion.
In 2008, the domestic pharmaceuticals market in India was expected to be US$ 10.76 billion and this is likely to increase at a compound annual growth rate of 9.9 per cent until 2010 and subsequently at 9.5per cent till the year 2015.
The Indian Pharmaceutical Industry is one of the biggest producers of the active Pharmaceutical ingredients (API) in the international arena.
Contribution of Contribution of Pharmaceutical Industry to Indian Pharmaceutical Industry to Indian GDPGDP
The Indian Pharmaceuticals Industry includes small scaled, medium scaled, large scaled players, which totals nearly 300different companies. There are several other small units operating in the domestic sector.
The sales of the Indian Pharmaceutical Industry would be worth US$ 43billion within the next decade.
The Pharmaceuticals Industry in India produces around 20%to 24% of the global generic drugs.
Dr.REDDY’S LABDr.REDDY’S LAB
►►ESTABLISHED IN 1984ESTABLISHED IN 1984
Doctorate from the national Doctorate from the national chemical laboratory,punechemical laboratory,pune
TOP PHARMACEUTICAL COMPANY TOP PHARMACEUTICAL COMPANY ININ THE COUNTRYTHE COUNTRY
Dr.ANJI REDDY
Established in 1984, Dr. Reddy·s Laboratories (NYSERDY) is
an emerging global pharmaceutical company.
Dr. Reddy·s products are marketed globally, with a focus on
India, US, europe and Russia.
Dr. Reddy·s conducts research in the areas of metabolic
disorders, cardiovascular indications, anti-infective and
inflammation
The company has 60 active pharmaceutical ingredients to
manufacture drugs, critical care products, diagnostic kits and
biotechnology products.
The company has 6 FDA plants that produce active pharma
ingredients and 7 FDA inspected and ISO 9001 and ISO 14001c
ertified plants.
ACHIEVEMENTSACHIEVEMENTSPadmaPadma shri shri in 2001. in 2001. Dr. K. Anji reddy is also a Dr. K. Anji reddy is also a philanthropist.philanthropist.
Dr. K. AnjiDr. K. Anji reddy has reddy has received many awards and received many awards and honorshonors
►► 7500 employees working across 7500 employees working across the globe in more than 35 countriesthe globe in more than 35 countries
MD----SATISH KUMAR
TURNOVER OF RS. 537.70 CRORES
TOP COMPANIESTOP COMPANIES♣ RANBAXY LABORATORIES♣ CIPLA
♣ DR.REDDY'S LABORATORIES♣ NICHOLAS PIRAMAL♣ AUROBINDO PHARMA♣ LUPIN♣ CADILA HEALTHCARE♣ SUN PHARMACEUTICAL♣ WOCKHARDT and♣ ORCHID CHEMICAL
HISHIS QUALITIESQUALITIES
► Great man with the determination.
► Brave man who works while others sleep
► Thinking is the capital enterprise
►Sweat for the great vision
► 1300 people in the campus recruitment.
► 1/3 is the women
►“Mr Prabir Kumar Jha, Senior Vice-President and Global Head of Human Resources” said the information.
PRODUCTS OF DR. REDDYPRODUCTS OF DR. REDDY
SHARE PRICE SHARE PRICE on 05.10.2012on 05.10.2012
In NSE share price of Dr. reddy is 1697.30
IN BSE share price of Dr. reddy is 1693.30
Dr. Reddy·s Position in Dr. Reddy·s Position in Indian MarketIndian Market
Dr Reddy's Laboratories remained on top with consolidated net sales of Rs 5,283 crore during the nine months ended December 2009 as against Rs 4,862 crore in the same period of last year indicating a relatively lower growth of 8.7 per cent.
Dr. Reddy·s forayed into the rural markets in FY09 with launch of an exclusive portfolio of products targeted at the needs of people in rural India.
Adjusted EBITDA of Rs. 15,828 million is highest among pharmaceutical companies in India in the year 2009-10.
In 2009-10, share of revenue from the international businesses stood at 82%, with 18% coming from India.
Ratio analysisRatio analysis
Year 2012 2011 2010 2009
Current Ratio
1.7 1.66 1.49 1.85
Quick Ratio 1.84 1.91 1.45 2.13
Debt Equity Ratio
0.23 0.24 0.1 0.12
Dr Reddy's Laboratories remained on top with consolidated net sales of Rs 5,283 crore during the nine months ended December 2009 as against Rs 4,862 crore in the same period of last year indicating a relatively lower growth of 8.7 per cent.
Dr. Reddy·s forayed into the rural markets in FY09 with launch of an exclusive portfolio of products targeted at the needs of people in rural India.
Adjusted EBITDA of Rs. 15,828 million is highest among pharmaceutical companies in India in the year 2009-10.
In 2009-10, share of revenue from the international businesses stood at 82%, with 18% coming from India.
PROFITABILITY RATIOSPROFITABILITY RATIOS
2012 2011
Profit margin 17.42 24.76
Return on assets 286.12 350.30
Return on equity 10.55 15.87
Assets turnover 1.97 1.86
Earning per share 28.26 50.11
Thank youThank you
Related Documents
